Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168216 | 1.00 | — | — | |
| SCHEMBL10950637 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL28575007 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL6381540 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL28576746 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL28914313 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL8032226 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL4238846 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TDP1LMNAMEN1KMT2A | |
| SCHEMBL2167079 | 0.97 | — | — | |
| SCHEMBL437912 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112911942-A | Aqueous composition comprising omega-nitrooxy-1-alkanol | 帝斯曼知识产权资产管理有限公司 | 2021-06-04 | — | — | CN | disclosed |
| US-9783833-B2 | Biocatalytic methods to convert cyclohexane oxidation process waste streams to useful products | INVISTA NORTH AMERICA S.A.R.L. (US) | 2017-10-10 | — | — | US | disclosed |
| US-9775241-B2 | Nanotube dispersants and dispersant free nanotube films therefrom | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| EP-2717864-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | Dietz, Ulrich (DE) | 2014-04-16 | — | — | EP | disclosed |
| US-20140099354-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | Dietz, Ulrich (DE) | 2014-04-10 | — | — | US | disclosed |
| US-8609873-B2 | Process for making and using HOF.RCN | THE SECRETARY OF STATE FOR DEFENSE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 2013-12-17 | — | — | US | disclosed |
| WO-2012168342-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | DIETZ ULRICH (DE) | 2012-12-13 | — | — | WO | disclosed |
| CN-101172957-B | Novel compound, synthetic method thereof and therapeutic usage | GILEAD SCIENCES INC (US) | 2012-11-14 | — | — | CN | disclosed |
| US-20110040092-A1 | PROCESS FOR MAKING AND USING HOF.RCN | THE SECRETARY OF STATE FOR DEFENSE (GB) | 2011-02-17 | — | — | US | disclosed |
| EP-2188046-A2 | A PROCESS FOR MAKING AND USING HYPOFLUOROUS ACID (HOF)/NITRILE (RCN) COMPLEXES . | The Secretary of State For Defence (GB) | 2010-05-26 | — | — | EP | disclosed |
| US-20050176758-A1 | 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors | GILEAD SCIENCES, INC. | 2005-08-11 | — | — | US | disclosed |
| CN-1185223-C | Novel compounds, their synthesis and therapeutic use | GILEAD SCIENCES INC (US) | 2005-01-19 | — | — | CN | disclosed |
| US-6225341-B1 | FOR INHIBITING NEURAMINIDASE; FOR THERAPY AND PROPHYLAXIS OF VIRUS INFECTION | GILEAD SCIENCES, INC. | 2001-05-01 | — | — | US | disclosed |
| EP-0759917-B1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES INC (US) | 2000-04-12 | — | — | EP | disclosed |
| CN-1147813-A | Novel compounds, their synthesis and therapeutic use | GILEAD SCIENCES INC (US) | 1997-04-16 | — | — | CN | disclosed |
| WO-1996026933-A9 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | — | 1996-11-28 | — | — | WO | disclosed |
| CN-86108089-A | New tetrahydro isoquinoline derivative | — | 1987-09-16 | — | — | CN | disclosed |
| EP-0229944-A2 | Novel tetrahydroisoquinoline derivatives | SYNTEX (U.S.A.) INC. (US) | 1987-07-29 | — | — | EP | disclosed |
| US-4681889-A | ANGINA, HYPERTENSION, CONGESTIVE HEART FAILURE | SYNTEX (U.S.A.) INC. (US) | 1987-07-21 | — | — | US | disclosed |
| US-4613606-A | CARDIOVASCULAR DISORDERS | SYNTEX (U.S.A.) INC. (US) | 1986-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140099354-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | PHOSPHO1, PTDSS1, LIPG | ALDH1A1 2921/4885TDP1 2044/4885LMNA 338/4885 |
| US-20110040092-A1 | PROCESS FOR MAKING AND USING HOF.RCN | HMOX2, FSCN1, POLN | ALDH1A1 575/4885TDP1 2265/4885LMNA 3021/4885 |
| US-20050176758-A1 | 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors | NEU3, NEU1, NEU4 | ALDH1A1 374/4885TDP1 2496/4885LMNA 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.